QNCX Competitors & Alternatives
Compare Quince Therapeutics, Inc. with similar stocks in the same industry
Biotechnology
QNCX
Main Stock$17.23
Tradestie Score
48
Market Cap
$87.02M
Analyst Upside
+403.0%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ANRO
Alto Neuroscience Inc.
|
$24.78
|
$110.20M | - | 58 | Compare |
|
OVID
Ovid Therapeutics Inc. Common Stock
|
$2.69
|
$97.42M | - | 55 | Compare |
|
STRO
Sutro Biopharma, Inc.
|
$30.43
|
$76.55M | - | 58 | Compare |
|
RLMD
Relmada Therapeutics, Inc. Common Stock
|
$6.28
|
$71.69M | - | 52 | Compare |
|
IMMX
Immix Biopharma, Inc. Common Stock
|
$10.34
|
$67.94M | - | 56 | Compare |
|
MGRX
Mangoceuticals, Inc. Common Stock
|
$0.47
|
$24.13M | - | 53 | Compare |
|
AIXI
XIAO-I Corporation American Depositary Shares
|
$1.89
|
$15.99M | - | 48 | Compare |
|
DRMA
Dermata Therapeutics, Inc. Common Stock
|
$1.34
|
$3.50M | - | 49 | Compare |
|
VRAX
Virax Biolabs Group Limited Ordinary Shares
|
$3.13
|
$2.69M | - | 50 | Compare |
|
RENX
RENX
|
$2.00
|
- | - | 53 | Compare |
More QNCX Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry